GSK has selected a site currently being constructed on the corner of New Oxford Street and Earnshaw Street – known as the Earnshaw building – for its new HQ, which is currently located to the ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

In oncology, GSK has been building a portfolio of “antibody drug conjugates”, a new type of chemotherapy that aims to kill cancerous cells while sparing healthy ones. Late last year ...

Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...